He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
This has further strengthened its manufacturing presence in the United States of America
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024
Subscribe To Our Newsletter & Stay Updated
